Skip to main content
. 2025 Jul 14;13(14):1691. doi: 10.3390/healthcare13141691
ACPA anti-citrullinated protein antibodies
APS antiphospholipid syndrome
AS atherosclerosis
DMARD disease-modifying antirheumatic drugs
bDMARDs biologic disease-modifying antirheumatic drugs
CAD coronary artery disease
CRP C-reactive protein
CVD cardiovascular disease
DM diabetes mellitus
EBV Epstein-Barr virus
EULAR European Alliance of Associations for Rheumatology
FLS fibroblast-like synoviocytes
HDL high-density lipoprotein
ICAM-1 intercellular adhesion molecule-1
IL-1 interleukin-1
IL-1β interleukin-1 beta
IL-6 interleukin-6
LDL low-density lipoprotein
MMPs matrix metalloproteinases
MRI magnetic resonance imaging
NF-κB kappa-light-chain-enhancer of activated B cells
NSAIDs nonsteroidal anti-inflammatory drugs
OA osteoarthritis
RA rheumatoid arthritis
RF rheumatoid factor
SLE systemic lupus erythematosus
TENS transcutaneous electrical nerve stimulation
TNF-α factor-alpha
VCAM-1 vascular cell adhesion molecule-1
WHO World Health Organization